Curcumin Disrupts a Positive Feedback Loop between ADMSCs and Cancer Cells in the Breast Tumor Microenvironment via the CXCL12/CXCR4 Axis

被引:11
|
作者
Jang, Bo-Young [1 ]
Shin, Min Kyoung [1 ]
Han, Dong-Hee [1 ]
Sung, Jung-Suk [1 ]
机构
[1] Dongguk Univ Seoul, Dept Life Sci, Goyang 10326, South Korea
基金
新加坡国家研究基金会;
关键词
curcumin; breast cancer; cancer-associated fibroblast; tumor microenvironment; adipose-derived mesenchymal stem cell; CXCL12/CXCR4; axis; NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; SIGNALING PATHWAY; PANCREATIC-CANCER; CXCR4; ERK;
D O I
10.3390/pharmaceutics15112627
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adipose tissue has a significant impact on breast cancer initiation and progression owing to its substantial proportion in the breast. Adipose-derived mesenchymal stem cells (ADMSCs) are major players in the breast tumor microenvironment (TME) as they interact with cancer cells. The intricate interaction between ADMSCs and cancer cells not only drives the differentiation of ADMSCs into cancer-associated fibroblasts (CAFs) but also the metastasis of cancer cells, which is attributed to the CXCL12/CXCR4 axis. We investigated the effects of curcumin, a flavonoid known for CXCL12/CXCR4 axis inhibition, on breast TME by analyzing whether it can disrupt the ADMSC-cancer positive loop. Using MCF7 breast cancer cell-derived conditioned medium (MCF7-CM), we induced ADMSC transformation and verified that curcumin diminished the phenotypic change, inhibiting CAF marker expression. Additionally, curcumin suppressed the CXCL12/CXCR4 axis and its downstream signaling both in ADMSCs and MCF7 cells. The CM from ADMSCs, whose ADMSC-to-CAF transformation was repressed by the curcumin treatment, inhibited the positive feedback loop between ADMSCs and MCF7 as well as epithelial-mesenchymal transition in MCF7. Our study showed that curcumin is a potent anti-cancer agent that can remodel the breast TME, thereby restricting the ADMSC-cancer positive feedback loop associated with the CXCL12/CXCR4 axis.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression
    Xueqing Sun
    Guangcun Cheng
    Mingang Hao
    Jianghua Zheng
    Xiaoming Zhou
    Jian Zhang
    Russell S. Taichman
    Kenneth J. Pienta
    Jianhua Wang
    Cancer and Metastasis Reviews, 2010, 29 : 709 - 722
  • [22] CXCL12/CXCR4 axis in the microenvironment of solid tumors: A critical mediator of metastasis
    Mortezaee, Keywan
    LIFE SCIENCES, 2020, 249
  • [23] The CXCL12/CXCR4/ACKR3 Axis in the Tumor Microenvironment: Signaling, Crosstalk, and Therapeutic Targeting
    Smit, Martine J.
    Schlecht-Louf, Geraldine
    Neves, Maria
    van den Bor, Jelle
    Penela, Petronila
    Siderius, Marco
    Bachelerie, Francoise
    Mayor, Federico, Jr.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021, 2021, 61 : 541 - 563
  • [24] Importance of CXCL12, CXCR4 and CXC7 in breast cancer cells
    Hawsawi, Nahed M.
    May, Felicity E. B.
    CANCER RESEARCH, 2010, 70
  • [25] Role of CXCL12/CXCR4 signaling axis in radiation resistant pancreatic cancer cells
    Imafuji, Hiroyuki
    Matsuo, Yoichi
    Kuzuya, Hiromasa
    Ueda, Goro
    Omi, Kan
    Hayashi, Yuichi
    Saito, Kenta
    Tsuboi, Ken
    Morimoto, Mamoru
    Takahashi, Hiroki
    Ishiguro, Hideyuki
    Takiguchi, Shuji
    CANCER SCIENCE, 2018, 109 : 860 - 860
  • [26] Possible Diagnostic Application of CXCL12 and CXCR4 as Tumor Markers in Breast Cancer Patients
    Dabrowska, Emilia
    Przylipiak, Andrzej
    Zajkowska, Monika
    Piskor, Barbara M.
    Sidorkiewicz, Iwona
    Szmitkowski, Maciej
    Lawicki, Slawomir
    ANTICANCER RESEARCH, 2020, 40 (06) : 3221 - 3229
  • [27] Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer
    Mao, T. L.
    Fan, K. F.
    Liu, C. L.
    GENE THERAPY, 2017, 24 (10) : 621 - 629
  • [28] Potential of CXCR4/CXCL12 Chemokine Axis in Cancer Drug Delivery
    Wang Y.
    Xie Y.
    Oupický D.
    Current Pharmacology Reports, 2016, 2 (1) : 1 - 10
  • [29] Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer
    T L Mao
    K F Fan
    C L Liu
    Gene Therapy, 2017, 24 : 621 - 629
  • [30] Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer
    Yasumoto, K
    Koizumi, K
    Kawashima, A
    Saitoh, Y
    Arita, Y
    Shinohara, K
    Minami, T
    Nakayama, T
    Sakurai, H
    Takahashi, Y
    Yoshie, O
    Saiki, I
    CANCER RESEARCH, 2006, 66 (04) : 2181 - 2187